A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Community Health Education, Telephone Based Intervention.
- Who it may be relevant to
- Registry conditions: Healthy. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
I Can Join the Fight Against Cancer: An Intervention to Programmatically Build Grassroots Actions to Reduce the Cancer Burden
Overview
This clinical trial evaluates a community health education intervention (I CAN) for increasing community-driven actions to reduce the cancer burden in Western New York. Engaging community members is a critical component of designing impactful programs to reduce the cancer burden. Leaders at the national, state, and local levels have all called for more community partnerships and engagement in design of health intervention and policies. The I CAN intervention is a workshop that includes a presentation outlining key concepts related to social network processes and the cancer burden in Western New York, a structured skill-building activity, and then empowering and motivating activities meant to cultivate momentum and excitement for action. This community health education intervention may be able to provide a formalized process for empowering and facilitating community members to take steps to reduce the community cancer burden.
Detailed description
PRIMARY OBJECTIVES:
I. Examine the feasibility of the I CAN intervention. (Phase I) II. Examine the acceptability of the I CAN intervention. (Phase I) III. Examine topic areas selected for action within participants' I CAN plans for action. (Phase I) IV. Determine whether the I CAN intervention will result in higher number of individuals who complete lung cancer screening compared to didactic educational control. (Phase 2 \[Effectiveness of intervention trial for lung cancer screening\]) V. To evaluate whether the I CAN intervention improves adherence to recommended annual lung cancer screening follow-up among participants who initially received low dose computed tomography of the chest (LDCT) screening. (Phase 2 \[Effectiveness of intervention trial for lung cancer screening\]) VI. To assess whether the I CAN intervention results in different levels of lung cancer screening knowledge and self-efficacy compared to the control group. (Phase 2 \[Effectiveness of intervention trial for lung cancer screening\])
OUTLINE:
Participants are assigned to 1 of 2 phases. Phase I - Participants attend an I CAN intervention workshop over 2 hours. Phase 2 - Community-based programs are randomized to 1 of 2 arms and participants are assigned to the arm to which their community-based program was randomized.
Interventions
- Procedure Community Health Education
Receive I CAN intervention - Behavioral Telephone Based Intervention
Receive coaching call
Primary outcome measures
- Demand - Phase 1 [Time frame: Up to 2 years]
- Practicality - Phase 1 [Time frame: Up to 2 years]
- Acceptability- Phase 1 [Time frame: UP to 2 years]
- Lung Cancer Screening Uptake [Time frame: Up to 2 years]
Eligibility criteria
Inclusion criteria
- Being over 18 years old
- Able to participate in English
Exclusion criteria
- Unwilling or unable to follow protocol requirements
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
United States · 1 center
- Roswell Park Cancer Institute — Buffalo
Identifiers
NCT: NCT06681077 · I 4186824 · NCI-2024-09012 · I 4186824